Profile | GDS2987 / GI_20127635-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 1.3 | 5 |
GSM215244 | HMVEC_vehicle_rep2 | 2.8 | 7 |
GSM215253 | HMVEC_vehicle_rep3 | 3.2 | 11 |
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | 0.2 | 0 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 0.7 | 1 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 7.9 | 14 |
GSM215294 | HMVEC_SLx2119_rep1 | 11.5 | 39 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 18.9 | 31 |
GSM215297 | PASMC_vehicle_rep1 | 50.3 | 59 |
GSM215298 | PASMC_vehicle_rep2 | 31.3 | 44 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 52.8 | 64 |
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 29.6 | 45 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 23.5 | 42 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 14.8 | 25 |
GSM215327 | PASMC_SLx2119_rep1 | 24.2 | 40 |
GSM215328 | PASMC_SLx2119_rep2 | 20.6 | 36 |
GSM215329 | PASMC_SLx2119_rep3 | 27.4 | 47 |
GSM215330 | Fibroblasts_vehicle_rep1 | 4.1 | 10 |
GSM215331 | Fibroblasts_vehicle_rep2 | ||
GSM215332 | Fibroblasts_vehicle_rep3 | 9.5 | 31 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 20 | 47 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | ||
GSM215335 | Fibroblasts_atorvastatin_rep3 | 1.8 | 5 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 17.5 | 49 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 25.5 | 59 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 12.6 | 34 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 15.1 | 41 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 29.4 | 59 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 11.8 | 29 |